Lineage Cell Therapeutics (LCTX) Invested Capital (2013 - 2021)
Lineage Cell Therapeutics (LCTX) recorded Invested Capital of $117.09 million in Q1 2021, up 22.4% from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Invested Capital (2013 - 2021) Analysis & Trends
For FY2020, Lineage Cell Therapeutics reported Invested Capital of $95.65 million.
- Annual Invested Capital has a five-year compound annual growth rate of 4.5% (FY2015 to FY2020).
- Across earlier years, Invested Capital came in at $92.32 million in FY2018 (-43.9%), $164.43 million in FY2017 (+25.1%) and $131.46 million in FY2016 (+71.2%).
- The Q1 2021 figure is the highest quarterly Invested Capital since Q1 2019.
- Peak year-over-year performance for Invested Capital in the last five years was growth of 218.6% in Q1 2017, against a decline of 46.3% in Q1 2018 at the low end.
- Per Business Quant, the preceding three quarters came in at $95.65 million (Q4 2020), $90.71 million (Q3 2020) and $98.22 million (Q2 2020).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 134.01 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 64.89 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 95.89 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 79.44 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 50.26 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 68.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 38.08 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 148.69 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Lineage Cell Therapeutics | 240.26 Mn | 38.67 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2021 | 117.09 Mn |
| Dec 31, 2020 | 95.65 Mn |
| Sep 30, 2020 | 90.71 Mn |
| Jun 30, 2020 | 98.22 Mn |
| Mar 31, 2019 | 161.25 Mn |
| Dec 31, 2018 | 92.32 Mn |
| Sep 30, 2018 | 169.63 Mn |
| Jun 30, 2018 | 104.87 Mn |
| Mar 31, 2018 | 102.58 Mn |
| Dec 31, 2017 | 164.43 Mn |
| Sep 30, 2017 | 209.16 Mn |
| Jun 30, 2017 | 180.84 Mn |
| Mar 31, 2017 | 190.86 Mn |
| Dec 31, 2016 | 131.46 Mn |
| Sep 30, 2016 | 136.77 Mn |
| Jun 30, 2016 | 94.32 Mn |
| Mar 31, 2016 | 59.91 Mn |
| Dec 31, 2015 | 76.79 Mn |
| Sep 30, 2015 | 61.46 Mn |
| Jun 30, 2015 | 65.19 Mn |
API Access
Lineage Cell Therapeutics Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();